Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | KYMR | QGEN | ||
| Company | Repligen Corp | Kymera Therapeutics Inc | Qiagen N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 125.85 | 84.81 | 33.44 | ||
| High | 126.83 | 86.90 | 33.44 | ||
| Low | 121.26 | 83.65 | 32.92 | ||
| Latest | 123.46 | 86.08 | 33.04 | ||
| Change | -2.97 | +1.45 | -0.47 | ||
| % Change | -2.35% | +1.71% | -1.40% | ||
| Volume | 995,200 | 446,100 | 1,657,800 | ||
| 20-Day Average Volume | 1,144,600 | 516,005 | 2,185,810 | ||
| Previous Close | 126.43 | 84.63 | 33.51 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 123.42 | 85.71 | 37.42 | ||
| 20-Day Raw Stochastic | 43.69% | 67.51% | 1.28% | ||
| 20-Day Relative Strength | 50.18 | 53.02 | 27.35 | ||
| Weighted Alpha | -5.79 | +84.40 | -36.44 | ||
| Today's Opinion | 56% Sell | 88% Buy | 100% Sell | ||
| Previous Opinion | 56% Sell | 72% Buy | 100% Sell | ||
| Last Month's Opinion | 72% Sell | 88% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.34% since 05/01/26 | +6.65% since 05/01/26 | -3.53% since 05/01/26 | ||
| Low | 116.05 on 05/04/26 | 79.18 on 05/04/26 | 32.92 on 05/08/26 | ||
| High | 131.53 on 05/06/26 | 86.90 on 05/08/26 | 34.54 on 05/06/26 | ||
| 1-Month | |||||
| %Chg | +3.08% since 04/08/26 | -1.21% since 04/08/26 | -19.94% since 04/08/26 | ||
| Low | 109.50 on 04/23/26 | 77.64 on 04/30/26 | 32.92 on 05/08/26 | ||
| High | 141.46 on 04/21/26 | 90.14 on 04/15/26 | 42.33 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | -13.17% since 02/06/26 | +8.15% since 02/06/26 | -35.15% since 02/06/26 | ||
| Low | 109.50 on 04/23/26 | 73.31 on 03/24/26 | 32.92 on 05/08/26 | ||
| High | 146.36 on 02/10/26 | 95.90 on 02/26/26 | 52.20 on 02/13/26 | ||
| 6-Month | |||||
| %Chg | -13.56% since 11/07/25 | +46.74% since 11/07/25 | -27.94% since 11/07/25 | ||
| Low | 109.50 on 04/23/26 | 58.87 on 11/10/25 | 32.92 on 05/08/26 | ||
| High | 175.77 on 01/06/26 | 103.00 on 12/08/25 | 57.81 on 01/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,964,132 | 7,080,770 | 6,808,718 | ||
| Shares Outstanding, K | 56,408 | 82,258 | 206,075 | ||
| Annual Sales | 738,260,000 | 39,210,000 | 2,090,000,000 | ||
| Annual Net Income | 48,890,000 | -311,350,000 | 424,880,000 | ||
| Last Quarter Sales | 197,910,000 | 34,370,000 | 540,420,000 | ||
| Last Quarter Net Income | 13,290,000 | -69,230,000 | 107,830,000 | ||
| 60-Month Beta | 1.09 | 2.06 | 0.64 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.48 on 05/05/26 | -0.71 on 04/30/26 | 0.54 on 05/06/26 | ||
| Earnings Date | 08/04/26 | 08/10/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | 0.250 on 07/02/25 | ||
| Next Ex-Dividends Date | N/A | N/A | 07/02/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 70.24 | 0.00 | 13.77 | ||